Results 251 to 260 of about 87,208 (292)

Supplementary Figure S4 from Chemoradiotherapy and Subsequent Immunochemotherapy as Conversion Therapy in Unresectable Locally Advanced Esophageal Squamous Cell Carcinoma: A Phase II NEXUS-1 Trial

Xin Wang, Xiaozheng Kang, Ruixiang Zhang, Liyan Xue, Jiaqi Xu, Xiaotian Zhao, Qiuxiang Ou, Nuo Yu, Guojie Feng, Jiao Li, Ziyu Zheng, Xiankai Chen, Zhen Wang, Qingfeng Zheng, Yong Li, Jianjun Qin, Nan Bi, Yin Li   +17 more
openalex   +1 more source

Efficacy and Safety of Concurrent Chemoradiotherapy as First-Line Treatment for Stage IVB Cervical Cancer: A Single-Center Retrospective Observational Study. [PDF]

J Obstet Gynaecol Res
Ishidera Y, Iijima T, Aichi M, Ogawara Y, Imai Y, Sugiura M, Hata M, Miyagi E, Mizushima T.   +8 more
europepmc   +1 more source

Biomarker study on pneumonitis in durvalumab maintenance therapy after chemoradiotherapy for stage III non-small cell lung cancer. [PDF]

BMC Cancer
Yano R, Tokito T, Murotani K, Murata D, Tsuneyoshi S, Ishii H, Azuma K, Hoshino T.   +7 more
europepmc   +1 more source

Esophagectomy Versus Active Surveillance After Complete Response in Locally Advanced Esophageal Cancer: Retrospective Analysis. [PDF]

Cancers (Basel)
Gur E, Lutsyk M, Meirson T, Hjool NA, Limon D, Landman Y, Icht O, Brenner B, Kundel Y.   +8 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

[Chemoradiotherapy].

Nihon Geka Gakkai zasshi, 2008
In Western countries, chemotherapy or chemoradiotherapy followed by surgery is the standard treatment and definitive chemoradiotherapy is also standard treatment option for localized advanced esophageal cancer. On the other hand, in Japan, only surgery is recognized as standard of care.
Marcel Verheij, Harry Bartelink
  +5 more sources

Pancreatic cancer chemoradiotherapy

Best Practice & Research Clinical Gastroenterology, 2016
Pancreatic cancer is the most lethal gastrointestinal tumour. Chemotherapy is the mainstay of therapy in the majority of the patients whereas resection is the only chance of cure but only possible in 15-20% of all patients. The integration of radiotherapy into multimodal treatment concepts is heavily investigated.
Brunner, Thomas, Seufferlein, Thomas
openaire   +3 more sources

Chemoradiotherapy in Gastrointestinal Malignancies

Clinical Oncology, 2009
Over the past 30 years, significant advances have been made in the integration of radiation therapy and chemotherapy in the treatment of patients with localised gastrointestinal malignancies. The therapeutic goal of chemoradiotherapy is to enhance local control resulting in improved survival and outcome of these patients. To define the optimal sequence,
C G, Willett, B G, Czito
openaire   +2 more sources

Chemoradiotherapy in gallbladder cancer

Journal of Surgical Oncology, 2006
AbstractGallbladder cancer (GC) is considered a rare disease associated with a poor prognosis. Unfortunately, the low number of cases makes the performance of trials addressing the role of adjuvant, neoadjuvant, and/or palliative therapy difficult. For a long time, the majority of trials were 5‐fluorouracil (5 FU)‐based, and results were uniformly poor.
Aretxabala, Xabier de, Roa, Juan Carlos, León, Jorge, Maluenda, Fernando, Roa, Iván, Berríos Flores, Marcela Paz, Hepp, Juan, Gallardo, Jorge, Córdova, Andrés   +8 more
openaire   +2 more sources